Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

G Emmi, A Bettiol, E Gelain, IM Bajema… - Nature Reviews …, 2023 - nature.com
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …

Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management

G Trivioli, A Marquez, D Martorana, M Tesi… - Nature Reviews …, 2022 - nature.com
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises
granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic …

[HTML][HTML] EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

B Hellmich, B Sanchez-Alamo, JH Schirmer… - Annals of the …, 2024 - ard.bmj.com
Background Since the publication of the EULAR recommendations for the management of
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …

Eosinophilic granulomatosis with polyangiitis–advances in pathogenesis, diagnosis, and treatment

J Fijolek, E Radzikowska - Frontiers in Medicine, 2023 - frontiersin.org
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disease characterized by
eosinophil-rich granulomatous inflammation and necrotizing vasculitis, pre-dominantly …

[PDF][PDF] Systemic vasculitis: one year in review 2023

M Moretti, E Treppo, S Monti, G La Rocca… - Clin Exp …, 2023 - clinexprheumatol.org
Systemic vasculitides are heterogeneous disabling diseases characterised by chronic
inflammation of the blood vessels potentially leading to tissue destruction and organ failure …

The neutrophil: A key resourceful agent in immune‐mediated vasculitis

K Aymonnier, J Amsler, P Lamprecht… - Immunological …, 2023 - Wiley Online Library
The term “vasculitis” refers to a group of rare immune‐mediated diseases characterized by
the dysregulated immune system attacking blood vessels located in any organ of the body …

[HTML][HTML] Comparison of the 2022 ACR/EULAR classification criteria for antineutrophil cytoplasmic antibody-associated vasculitis with previous criteria

JY Pyo, LE Lee, YB Park, SW Lee - Yonsei medical journal, 2023 - ncbi.nlm.nih.gov
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises group of
small vessel vasculitides, including granulomatosis with polyangiitis (GPA), microscopic …

ANCA associated vasculitis subtypes: recent insights and future perspectives

K Austin, S Janagan, M Wells… - Journal of …, 2022 - Taylor & Francis
The ANCA associated vasculitides (AAVs) affect a range of internal organs including ear
nose and throat, respiratory tract, kidneys, skin and nervous system. They include …

Environmental factors influencing the risk of ANCA-associated vasculitis

WM Zhao, ZJ Wang, R Shi, YY Zhu, S Zhang… - Frontiers in …, 2022 - frontiersin.org
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of
diseases characterized by inflammation and destruction of small and medium-sized blood …

[HTML][HTML] Classification and epidemiology of vasculitis: Emerging concepts

T Ecclestone, RA Watts - Best Practice & Research Clinical Rheumatology, 2023 - Elsevier
The recent publication of the American College of Rheumatology (ACR)-European Alliance
of Associations for Rheumatology (EULAR) classification criteria for large vessel vasculitis …